MAY 28th 2025

Gourmey Sets New Cost Benchmark in Cultivated Meat Production with $3.4/lb Model Independently Validated

Gourmey’s 5,000-liter bioreactor system can achieve a production cost of $3.43 per pound, the lowest in the industry to date with independent validation (Credit to Cyril Marcilhacy)

Table of content

About Gourmey

About Arthur D. Little

Press Contact

Global management consulting firm Arthur D. Little, confirms that Gourmey’s production platform demonstrates a clear path to cost-competitive, scalable cultivated meat. The independent assessment validates a production cost of €7/kg ($3.43/lb) at commercial scale — the lowest figure reported to date in any third-party techno-economic model — and confirms that economically viable production is no longer theoretical, but within reach.

Paris, France – May 28th, 2025 — Gourmey, France’s pioneering cultivated food company, has become the first in the category to receive independent validation of a production model that’s both scalable and economically viable. A new techno-economic assessment from Arthur D. Little confirms that Gourmey’s 5,000-liter bioreactor system can reach production of cultivated meat at $3.43 per pound (€7 per kilogram), placing the company on a real-world path to price parity without relying on speculative technologies or mega-scale infrastructure.

Gourmey has taken a significant step forward with a validated production model and demonstrated a path to cost-efficiency. Its platform is built around a second-generation technology stack designed for cost-effective deployment, combining continuous production, undifferentiated cell biomass, and suspension-based cell cultures to support efficiency, consistency, and global scalability.

The analysis from Arthur D. Little highlights the strength of Gourmey’s second-generation approach, which replaces legacy biopharma techniques with food-grade, cost-effective processes purpose-built for scale. By designing a system that avoids reliance on complex inputs or custom infrastructure, Gourmey has established an asset-light production model for global scalability with minimal capital requirements compared to traditional systems.

Arthur D. Little’s analysis confirms that Gourmey’s model can, upon achievable and clearly defined process optimizations, deliver:

€7/kg ($3.4/lb) production cost at current 5,000L scale
CapEx under €35M per facility, modular and repeatable, with output of 1,700 tons (3M+ pounds) using just six 5,000L bioreactors
Continuous runs with high cell density
Cell feed at €0.20/L, with no growth factors or fetal bovine serum
Full suspension culture, eliminating the need for scaffolds or microcarriers
No reliance on pharmaceutical inputs

Gourmey’s platform was assessed to reach below €10/kg for finished product, the lowest cost level in publicly reported techno-economic models to date, [while] demonstrating best-in-class CapEx efficiency.,” said Clément Santander, Partner at Arthur D. Little. “This marks a shift from potential to proof.

Gourmey’s approach is grounded in B2B readiness, with strong culinary validation, global demand, and commercial partnerships already in place. Its first cultivated meat product, a cultured alternative to the iconic delicacy foie gras, is a high-margin entry and white space opportunity that has earned praise from Michelin-starred chefs and is backed by a culinary advisory board spanning Tokyo, San Francisco, and Copenhagen. The company has secured appetite from premium food service and distribution partners, with demand already exceeding planned production capacity. This product serves as a strategic launchpad for Gourmey’s broader portfolio, which includes additional poultry proteins and other species.

Gourmey’s cultivated meat product roasted by two-Michelin-star chef Rasmus Munk (Credit to Daniel Jensen)

Our focus has always been on building something technically sound, economically viable, and globally scalable to maximise our impact” said Nicolas Morin-Forest, co-founder and CEO of Gourmey. “The cultivated meat industry has reached a point where proof matters more than promises. This independent validation helps move the conversation forward to operational reality. It shows that, with the right technological choices supporting a realistic scale-up roadmap, cultivated proteins will become a meaningful solution to complement existing production systems.

Looking ahead, Gourmey’s advantage extends beyond economics. It is built on a proprietary embryonic stem cell platform and portfolio of more than 50 patent filings across the cultivated meat value chain, enabling species-agnostic scale, low-cost inputs, and continuous production without downstream complexity. With over €65 million raised, 7 regulatory filings underway in regions such as the EU, UK, Switzerland, Singapore, and the U.S., and a clear path to profitability, the company is now exploring tailored go-to-market strategies for both high-value offerings and future commodity proteins—including ongoing discussions with major global protein corporations.

Gourmey is preparing to enter international markets as one of the sector’s most advanced and de-risked players. Learn more at www.gourmey.com.

About Gourmey

Founded in 2019, Gourmey creates sustainable gourmet products directly from animal cells by combining food innovation with culinary arts. The company comprises a 60-strong international team at its food innovation center in Paris, France. Since its inception, Gourmey has secured over €65 million in public and private investments and is currently preparing for market entry, pending regulatory approvals in several regions. Gourmey focuses on providing new and delicious culinary experiences, with its flagship product set to offer a new choice for foie gras aficionados, chefs, and restaurants globally.

About Arthur D. Little

Arthur D. Little (ADL) is the world’s first management consulting firm, founded in 1886. For more than 135 years we have linked people, technology, and strategy to help organizations navigate complexity, unlock growth, and create sustainable impact. Operating through an open-consulting network of 50-plus offices in nearly 40 countries, ADL combines deep sector expertise with cutting-edge analytical tools and hands-on implementation support. Our multidisciplinary teams partner with corporations, scale-ups, and public institutions worldwide to accelerate performance, drive innovation through convergence and digital, and build resilient, future-ready operating models.

This assessment was conducted by Clément Santander, a Partner in ADL’s Paris office who specializes in supporting tech- and industrial-innovation scale-ups. Learn more at www.adlittle.com.

for press inquiries

Term and Conditions